Consensus BioNTech SE

Equities

BNTX

US09075V1026

Market Closed - Nasdaq 04:00:00 2024-03-28 pm EDT 5-day change 1st Jan Change
92.25 USD -0.77% Intraday chart for BioNTech SE +2.50% -12.59%

Evolution of the average Target Price on BioNTech SE

Price target over the last 5 years

History of analyst recommendation changes

fe03dd297.yLevlQafIR6JHIGeck6kRAS9RxBfaaeM6Bqyli-5Ckg.ufHqp2KqeVGxeuSoRj7FFCnyNXxsHeC6ui6KwGLgRmWS_ubSXtNwKbhZ8g~835b4a9e67ddf5af3317ef52229a7ca8
UBS Cuts BioNTech Price Target to $101 From $110, Maintains Neutral Rating MT
BIONTECH : Deutsche Bank remains Neutral ZD
TD Cowen Adjusts BioNTech Price Target to $95 From $101, Maintains Market Perform Rating MT
BIONTECH : A miss is a miss Alphavalue
BIONTECH : Deutsche Bank reaffirms its Neutral rating ZD
BIONTECH : Goldman Sachs reiterates its Neutral rating ZD
BIONTECH : Jefferies sticks Neutral ZD
BIONTECH : UBS gives a Neutral rating ZD
BMO Capital Initiates Coverage on BioNTech With Outperform Rating, $127 Price Target MT
Canaccord Genuity Adjusts Price Target on BioNTech to $171 From $168, Maintains Buy Rating MT
HC Wainwright Adjusts BioNTech Price Target to $107 From $133, Maintains Buy Rating MT
WHO sees 'incredibly low' COVID, flu vaccination rates as cases surge RE
BIONTECH : UBS sticks Neutral ZD
Oppenheimer Initiates BioNTech With Perform Rating MT
BIONTECH : UBS gives a Neutral rating ZD
BIONTECH : Jefferies remains Neutral ZD
Morgan Stanley Lifts Price Target on BioNTech to $112 From $111, Keeps Equalweight Rating MT
JPMorgan Chase Downgrades BioNTech to Underweight From Neutral, Cuts Price Target to $99 From $106 MT
BIONTECH : UBS sticks Neutral ZD
UBS Cuts BioNTech Price Target to $110 From $153, Maintains Neutral Rating MT
BIONTECH : Management focus is on a strong balance sheet Alphavalue
HC Wainwright Adjusts BioNTech SE Price Target to $133 From $180, Maintains Buy Rating MT
BIONTECH : Goldman Sachs sticks Neutral ZD
BIONTECH : Goldman Sachs remains Neutral ZD
BIONTECH : A more realistic view Alphavalue
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
85.92 EUR
Average target price
109.1 EUR
Spread / Average Target
+26.95%
High Price Target
173.2 EUR
Spread / Highest target
+101.63%
Low Price Target
82.88 EUR
Spread / Lowest Target
-3.54%

Consensus detail

Consensus revision (last 18 months)

Analysts covering BioNTech SE

UBS
DEUTSCHE BANK RESEARCH Emmanuel Papadakis
TD Cowen
alphavalue Martin Schnee
JEFFERIES Akash Tewari
GOLDMAN SACHS Chris Shibutani
BMO Capital
Canaccord Genuity
HC Wainwright
Oppenheimer
Morgan Stanley
JPMorgan Chase
JPMORGAN Jessica Fye
HSBC
Deutsche Bank Securities
BERENBERG Zhiqiang Shu
Redburn
Berenberg Bank
BofA Securities
Jefferies & Co.
SVB Securities LLC
Kempen
DEUTSCHE BANK Emmanuel Papadakis
SVB Leerink
BRYAN GARNIER Olga Smolentseva
Bryan, Garnier & Co.
Wolfe Research
J.P. Morgan Chase
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings